A district court in New Jersey ruled that the plaintiff lacked standing for certain claims, but there is a chance the case ...

We recently compiled a list of the Retirement Stock Portfolio: 10 Healthcare Stocks to Buy. In this article, we are going to ...

AD, The most common inflammatory skin disorder worldwide, is a highly heterogeneous condition with current treatments that do ...

Johnson & Johnson is one of several Dow Jones Industrial Average stocks reporting financial results this week. A look at the ...

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

With more than $85 billion in revenue, Johnson & Johnson is among the world’s top pharmaceutical companies. And with that industry dominance comes a slew of challenges relating to supply chain ...

In a report released today, Tim Anderson from Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Johnson & Johnson (JNJ – Research Report), with a ...

With FDA approval, J&J's Spravato is poised to capture a larger share of the mental health treatment market ... GuruFocus now and deep dive into Johnson and Johnson's performance with charts ...